Replies to post #14365 on Ariad Pharmaceuticals Inc fka ARIA

[JJM760]

I like the potential for the Hedgehog, but Cris sold of 90% of the Hh to Roche. Arias owns 100% of Ponatinib and 113. Each could potentially be a blockbuster (stress could potentially). Not many other bios can make that claim. That's been a common theme amongst some of the long term posters here for quite some time.

Just one of the reasons why I believe you would have to be out of your mind to think Ariad is a good short candidate.

Congrats to the maven. 1/2 of an 85% one day gain beats 0! ;0)